Is Headache in Macromastia Really Tension-Type? Insights From a Prospective Study

Headache is frequently listed among the symptoms reported by women with macromastia. Yet for decades, it has often been labeled as “tension-type” without formal diagnostic classification. A recent study published in Cephalalgia Reports suggests that assumption may be incorrect.

In this blog, we break down what the data show, why it matters clinically, and how it may change the way we evaluate women with macromastia and recurrent headache.

The Study at a Glance

Title: Understanding headache in the context of macromastia: An observational pilot study of headache profiles and postoperative changes
Published: February 2, 2026
Journal: Cephalalgia Reports
DOI: 10.1177/25158163261416853

This prospective cohort study followed 34 adult women with:

• Symptomatic macromastia
• At least four headache days per month
• Planned reduction mammoplasty

Participants were evaluated before surgery, at 12 to 16 weeks postoperatively, and again 19 to 28 months after surgery.

The primary question was simple but important:

How many of these patients actually have migraine?

What They Found: 91 Percent Screened Positive for Migraine

Using the ID Migraine screening tool and semi structured interviews aligned with the criteria of the International Headache Society, 91 percent of participants screened positive for migraine.

This directly challenges the long standing assumption in surgical literature that headache in macromastia is primarily tension type.

Even more notable:

• 58 percent met criteria for episodic migraine
• 42 percent met criteria for chronic migraine

That chronic migraine proportion is far higher than expected in general migraine populations.

Baseline Burden Was Severe

This was not a mild headache cohort.

At baseline:

• Median 10 headache days per month
• Mean pain intensity 6.2 out of 10
• Mean MIDAS score in the severe disability range
• 40 percent had cutaneous allodynia
• 56 percent screened high risk for obstructive sleep apnea
• 100 percent reported neck pain

Only 38 percent had previously been evaluated by a neurologist.

For clinicians, this highlights a potential under recognition of migraine phenotype in women presenting primarily for surgical consultation.

The Red Flag Issue: A Critical Detail

Although 91 percent screened positive for migraine, every participant reported at least one red flag feature such as:

• Pulsatile tinnitus
• Valsalva aggravated headache
• Visual dimming

These findings raise concern for secondary headache disorders, particularly idiopathic intracranial hypertension in obese women of reproductive age.

Importantly, the study did not include standardized neurologic examination or mandatory neuroimaging at baseline.

This leaves an open question:

Are we seeing migraine exacerbated by macromastia, a new secondary headache entity, or an underdiagnosed intracranial pressure disorder?

From a clinical perspective, red flags warrant careful evaluation before attributing symptoms to musculoskeletal strain alone.

What Happened After Surgery?

At both short term and long term follow up, participants demonstrated statistically significant improvements in:

• Monthly headache days
• Pain intensity
• Disability scores
• Allodynia
• Obstructive sleep apnea risk

At long term follow up, nearly 90 percent achieved at least 50 percent reduction in headache frequency.

Improvements were sustained up to 28 months postoperatively.

Patient satisfaction with surgery was high, reaching 100 percent at long term follow up.

What Might Explain the Improvement?

The mechanism remains unclear, but several hypotheses emerge.

1. Biomechanical Load Reduction

Chronic cervical and thoracic strain may contribute to peripheral sensitization. Reduction mammoplasty decreases mechanical traction.

2. Central Sensitization Modulation

Baseline rates of allodynia suggest central sensitization. Reduced nociceptive input could theoretically decrease central hyperexcitability.

3. Sleep Improvement

OSA risk scores improved postoperatively. Better sleep quality may reduce headache frequency.

4. Psychosocial Effects

Improved mood, exercise capacity, and body image may indirectly influence headache burden.

5. Obesity Interaction

Interestingly, higher BMI was associated with greater headache response, although weight loss itself did not explain improvements.

Reduction mammoplasty does not typically produce substantial systemic weight loss, so mechanisms likely extend beyond simple BMI reduction.

Clinical Implications

Do Not Default to “Tension-Type”

When women with macromastia report frequent headaches, migraine should be actively considered.

Screen for Red Flags

Symptoms such as pulsatile tinnitus and Valsalva aggravated pain should prompt further evaluation.

Consider Neurology Referral Before Surgery

A structured headache evaluation may:

• Clarify diagnosis
• Identify secondary causes
• Optimize preventive therapy
• Prevent delayed diagnosis of intracranial pathology

Avoid Overinterpretation

This was a small observational pilot study. It does not establish reduction mammoplasty as a treatment for migraine.

Causality cannot be inferred.

Why This Matters

Migraine disproportionately affects women in reproductive years. Macromastia also commonly presents in this demographic.

This overlap raises important questions:

• Could macromastia contribute to migraine chronification?
• Is there a distinct secondary headache disorder related to breast tissue burden?
• Does chronic cervical strain influence trigeminocervical convergence pathways?

These questions remain unanswered but are now firmly on the research agenda.

Strengths and Limitations

Strengths

• Prospective design
• Multidisciplinary collaboration
• Long term follow up
• Systematic use of validated tools

Limitations

• Small sample size
• No control group
• Recall based headache measurement
• No mandatory neurologic examination
• Possible placebo or expectancy effects
• Three participants initiated preventive migraine therapy during follow up

The findings are hypothesis generating, not definitive.

Bottom Line for Healthcare Professionals

Headache in macromastia may not be “just tension-type.” In this cohort:

• 91 percent screened positive for migraine
• Chronic migraine was common
• Red flag features were universal
• Postoperative improvements were substantial and sustained

Before assuming a purely musculoskeletal etiology, consider formal headache classification and evaluation for secondary causes.

Interdisciplinary collaboration between plastic surgeons and neurologists may improve patient outcomes and diagnostic accuracy.

Source

Pocock KS, Rigdon J, Wells RE, et al. Understanding headache in the context of macromastia: An observational pilot study of headache profiles and postoperative changes. Cephalalgia Reports. Published online February 2, 2026. doi:10.1177/25158163261416853

Disclaimer

This blog is intended for healthcare professionals. It summarizes findings from a single observational pilot study and does not establish causality or clinical guidelines. Reduction mammoplasty should not be recommended as a primary treatment for headache based solely on these findings. Clinical decisions should be individualized and grounded in comprehensive neurologic evaluation and current evidence.